Jichu yixue yu linchuang (Sep 2022)

Progress in the treatment with dopamine receptor agonist-induced impulse control disorders

  • ZHANG Rui, WU Xue-yan

DOI
https://doi.org/10.16352/j.issn.1001-6325.2022.09.1433
Journal volume & issue
Vol. 42, no. 9
pp. 1433 – 1437

Abstract

Read online

It is found that patients with hyperprolactinemia may have impulse control disorder(ICD) when treated with dopamine receptor agonist(DA), such as pathological gambling, high sexual desire, high appetite and forced shopping. This phenomenon also occurs in patients with Parkinson's disease (PD) or other neurological diseases treated with dopamine agonists. The pathogenesis may be that DA overstimulates D3 receptor. Drug withdrawal is a well accepted treatment method, which may reach a better catabatic outcome.

Keywords